5-150896165-G-A
Variant names:
Variant summary
Our verdict is Benign. The variant received -11 ACMG points: 0P and 11B. BP4_StrongBP6_ModerateBP7BS2
The NM_052860.4(ZNF300):c.1074C>T(p.Cys358Cys) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00075 in 1,612,918 control chromosomes in the GnomAD database, including 11 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.0036 ( 4 hom., cov: 32)
Exomes 𝑓: 0.00045 ( 7 hom. )
Consequence
ZNF300
NM_052860.4 synonymous
NM_052860.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.269
Genes affected
ZNF300 (HGNC:13091): (zinc finger protein 300) The protein encoded by this gene is a C2H2-type zinc finger DNA binding protein and likely transcriptional regulator. The function of this protein is not yet known. Three transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Mar 2010]
IRGM (HGNC:29597): (immunity related GTPase M) This gene encodes a member of the p47 immunity-related GTPase family. The encoded protein may play a role in the innate immune response by regulating autophagy formation in response to intracellular pathogens. Polymorphisms that affect the normal expression of this gene are associated with a susceptibility to Crohn's disease and tuberculosis. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Oct 2016]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -11 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.66).
BP6
Variant 5-150896165-G-A is Benign according to our data. Variant chr5-150896165-G-A is described in ClinVar as [Benign]. Clinvar id is 776080.Status of the report is criteria_provided_single_submitter, 1 stars.
BP7
Synonymous conserved (PhyloP=0.269 with no splicing effect.
BS2
High Homozygotes in GnomAd4 at 4 AR gene
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZNF300 | ENST00000274599.10 | c.1074C>T | p.Cys358Cys | synonymous_variant | Exon 6 of 6 | 1 | NM_052860.4 | ENSP00000274599.5 | ||
ZNF300 | ENST00000446148.7 | c.1074C>T | p.Cys358Cys | synonymous_variant | Exon 7 of 7 | 1 | ENSP00000397178.3 | |||
IRGM | ENST00000520549.1 | n.*141-4424G>A | intron_variant | Intron 3 of 3 | 1 | ENSP00000429819.1 | ||||
ZNF300 | ENST00000427179 | c.*1889C>T | 3_prime_UTR_variant | Exon 5 of 5 | 2 | ENSP00000414195.1 |
Frequencies
GnomAD3 genomes AF: 0.00361 AC: 548AN: 151734Hom.: 4 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
548
AN:
151734
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.000985 AC: 246AN: 249860 AF XY: 0.000718 show subpopulations
GnomAD2 exomes
AF:
AC:
246
AN:
249860
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000453 AC: 662AN: 1461064Hom.: 7 Cov.: 32 AF XY: 0.000391 AC XY: 284AN XY: 726824 show subpopulations
GnomAD4 exome
AF:
AC:
662
AN:
1461064
Hom.:
Cov.:
32
AF XY:
AC XY:
284
AN XY:
726824
Gnomad4 AFR exome
AF:
AC:
525
AN:
33448
Gnomad4 AMR exome
AF:
AC:
26
AN:
44564
Gnomad4 ASJ exome
AF:
AC:
0
AN:
26060
Gnomad4 EAS exome
AF:
AC:
0
AN:
39688
Gnomad4 SAS exome
AF:
AC:
0
AN:
86194
Gnomad4 FIN exome
AF:
AC:
1
AN:
53338
Gnomad4 NFE exome
AF:
AC:
62
AN:
1111668
Gnomad4 Remaining exome
AF:
AC:
44
AN:
60346
Heterozygous variant carriers
0
38
76
114
152
190
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00361 AC: 548AN: 151854Hom.: 4 Cov.: 32 AF XY: 0.00330 AC XY: 245AN XY: 74220 show subpopulations
GnomAD4 genome
AF:
AC:
548
AN:
151854
Hom.:
Cov.:
32
AF XY:
AC XY:
245
AN XY:
74220
Gnomad4 AFR
AF:
AC:
0.0125115
AN:
0.0125115
Gnomad4 AMR
AF:
AC:
0.00111417
AN:
0.00111417
Gnomad4 ASJ
AF:
AC:
0
AN:
0
Gnomad4 EAS
AF:
AC:
0
AN:
0
Gnomad4 SAS
AF:
AC:
0.00020816
AN:
0.00020816
Gnomad4 FIN
AF:
AC:
0
AN:
0
Gnomad4 NFE
AF:
AC:
0.000103075
AN:
0.000103075
Gnomad4 OTH
AF:
AC:
0.00237192
AN:
0.00237192
Heterozygous variant carriers
0
28
56
84
112
140
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Oct 19, 2017
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
Mutation Taster
=99/1
polymorphism
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at